Barnacle LLC has sold 84 lakh shares of Marksans Pharma through the open market route. The shares were sold on an average price of Rs 20.36 valuing the transaction to Rs 17.10 crore.
Marksans Pharma is engaged in production of prescription drugs, caters in areas like oncology, gastroenterology, antidiabetic, cardiovascular, pain management, gynaecology and others.
|
Thursday 5 June 2014
Barnacle LLC sells 84 lakh shares of Marksans Pharma
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment